AtriCure, Inc.
ATRC
$29.93
$0.401.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 534.53M | 518.31M | 499.95M | 480.08M | 465.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 534.53M | 518.31M | 499.95M | 480.08M | 465.31M |
| Cost of Revenue | 133.75M | 130.24M | 126.42M | 121.19M | 117.78M |
| Gross Profit | 400.78M | 388.06M | 373.52M | 358.88M | 347.52M |
| SG&A Expenses | 311.02M | 304.86M | 299.87M | 295.07M | 291.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 543.98M | 544.77M | 534.02M | 515.13M | 505.32M |
| Operating Income | -9.45M | -26.46M | -34.07M | -35.05M | -40.01M |
| Income Before Tax | -10.16M | -27.83M | -35.27M | -37.10M | -43.67M |
| Income Tax Expenses | 1.29M | 947.00K | 1.09M | 1.08M | 1.02M |
| Earnings from Continuing Operations | -11.45 | -28.77 | -36.36 | -38.18 | -44.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.45M | -28.77M | -36.36M | -38.18M | -44.70M |
| EBIT | -9.45M | -26.46M | -34.07M | -35.05M | -40.01M |
| EBITDA | 11.08M | -6.21M | -14.07M | -15.69M | -21.28M |
| EPS Basic | -0.24 | -0.61 | -0.77 | -0.81 | -0.95 |
| Normalized Basic EPS | -0.13 | -0.37 | -0.47 | -0.49 | -0.56 |
| EPS Diluted | -0.24 | -0.61 | -0.77 | -0.81 | -0.95 |
| Normalized Diluted EPS | -0.13 | -0.37 | -0.47 | -0.49 | -0.56 |
| Average Basic Shares Outstanding | 190.99M | 190.16M | 189.34M | 188.53M | 187.86M |
| Average Diluted Shares Outstanding | 191.91M | 190.16M | 189.34M | 188.53M | 187.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |